^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

anti-CD22-CAR

i
Associations
News
Company:
Kecellitics Biotech
Drug class:
CD22-targeted CAR-T immunotherapy
Related drugs:
Associations
News
Phase 1/2
Kecellitics Biotech Company Ltd
Unknown status
Last update posted :
12/23/2019
Initiation :
02/01/2020
Primary completion :
07/01/2021
Completion :
07/01/2022
CD22
|
CD22 expression
|
anti-CD22-CAR